Recent News

• 04.07.2025 - Lexeo Therapeutics Interim Phase 1/2 Data Update for LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy – 2025
• 04.07.2025 - Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
• 03.24.2025 - Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Recent Filings

• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.24.2025 - 8-K Current report
• 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.24.2025 - EX-99.1 EX-99.1
• 03.24.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.24.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities